HOXC6 and glioblastoma: By evaluating its prognostic value, performing an in-depth bioinformatics analysis, and verifying with the tumor cell biology experiments, we showed that HOXC6 could predict the survival of GBM patients and that its expression correlated with the cell cycle-related genes.